Ö. Ulusan Bagci Et Al. , "Molecular prevalence of Pneumocystis jirovecii and Cryptosporidium in patients with asthma," Diagnostic Microbiology and Infectious Disease , vol.108, no.1, 2024
Ulusan Bagci, Ö. Et Al. 2024. Molecular prevalence of Pneumocystis jirovecii and Cryptosporidium in patients with asthma. Diagnostic Microbiology and Infectious Disease , vol.108, no.1 .
Ulusan Bagci, Ö., Goksel, O., Gumusburun, R., Mert, U., Bogatekin, G., Töz, S., ... Caner, A.(2024). Molecular prevalence of Pneumocystis jirovecii and Cryptosporidium in patients with asthma. Diagnostic Microbiology and Infectious Disease , vol.108, no.1.
Ulusan Bagci, ÖZLEM Et Al. "Molecular prevalence of Pneumocystis jirovecii and Cryptosporidium in patients with asthma," Diagnostic Microbiology and Infectious Disease , vol.108, no.1, 2024
Ulusan Bagci, ÖZLEM U. Et Al. "Molecular prevalence of Pneumocystis jirovecii and Cryptosporidium in patients with asthma." Diagnostic Microbiology and Infectious Disease , vol.108, no.1, 2024
Ulusan Bagci, Ö. Et Al. (2024) . "Molecular prevalence of Pneumocystis jirovecii and Cryptosporidium in patients with asthma." Diagnostic Microbiology and Infectious Disease , vol.108, no.1.
@article{article, author={ÖZLEM ULUSAN BAĞCI Et Al. }, title={Molecular prevalence of Pneumocystis jirovecii and Cryptosporidium in patients with asthma}, journal={Diagnostic Microbiology and Infectious Disease}, year=2024}